The 6 Longevity Biomarkers That Actually Predict Lifespan — Biological Age Clocks, VO2max, ApoB, and What to Track

Updated: June 2026longevity biomarkers · biological age test · epigenetic clock · TruAge test · DunedinPACE aging · Horvath clock · VO2max longevity · ApoB cardiovascular risk · grip strength longevity · fasting insulin biomarker · hsCRP longevity · muscle mass longevity · HOMA-IR insulin resistance · biological age vs chronological age · how to test biological age · longevity blood test · best longevity biomarkers · age acceleration epigenetic · VO2max mortality risk Mandsager · ApoB vs LDL cardiovascular · longevity testing what to track · healthspan biomarkers · longevity lab tests 2026 · Inside Tracker longevity · Function Health longevity

Chronological age — the number of years since you were born — is the weakest predictor of healthspan and lifespan. Two people who are both 60 years old can have radically different biological ages, determined by their epigenetic state, cardiorespiratory fitness, metabolic health, and inflammatory burden. The actionable insight from longevity research is not that aging is inevitable at a fixed rate, but that the rate of aging is measurable, trackable, and modifiable through specific interventions.

The 2018 JAMA Network Open study by Mandsager et al. (N=122,007) demonstrated this starkly: VO2max (cardiorespiratory fitness) was the single strongest predictor of all-cause mortality in their dataset — stronger than smoking history, hypertension, or diabetes. The highest-fitness quintile had a 500% lower mortality risk than the lowest quintile over the follow-up period. The practical implication is that what you do with your body matters more than how old your birth certificate says you are — and measuring the right biomarkers tells you how much it's working.

500%
lower mortality for elite fitness — Mandsager 2018 (JAMA Network Open, N=122,007, mean follow-up 8.4 years): VO2max quintile analysis; elite fitness (top 2.3%) vs lowest fitness (bottom 25%) → HR 0.20 for all-cause mortality (5× lower risk); this was larger than the mortality hazard of smoking, hypertension, diabetes, or end-stage kidney disease in the same dataset; "cardiorespiratory fitness is arguably the most powerful clinical prognostic tool we have" (Levine 2018 editorial); VO2max is modifiable: Milanović 2015 meta-analysis: HIIT raises VO2max 5.5 mL/kg/min in ~10 weeks; Zone 2 raises it more slowly but more durably
DunPACE
DunedinPACE — the most responsive epigenetic clock; developed from the Dunedin Study (longitudinal birth cohort tracked from age 3 to 45); measures pace of aging (how many biological years passing per chronological year); normal = 1.0; high-risk individuals can be 1.3–1.4 (aging 1.3–1.4 biological years per year); DunedinPACE responds faster to interventions than Horvath clock: Fitzgerald 2021 (AGING journal, N=43 males): diet + supplement + sleep + exercise program → DunedinPACE deceleration -0.07 in 8 weeks; the "biological speedometer" vs Horvath's "odometer"; sold via TruAge and other labs
ApoB
ApoB — superior to LDL for cardiovascular risk; ApoB (apolipoprotein B) is the protein coat on every atherogenic lipoprotein particle (LDL, VLDL, IDL, Lp(a)); a single number representing the total number of particles that can enter arterial walls; superior to LDL-C because: 1 ApoB = 1 particle regardless of particle size; small dense LDL particles can have low LDL-C but high ApoB (the dangerous pattern); AMORIS study (N=175,553): ApoB was stronger predictor of MI than LDL-C; optimal ApoB: <60 mg/dL (aggressive longevity goal), <80 mg/dL (standard guideline); most standard lipid panels do NOT include ApoB — must be specifically ordered
Grip
grip strength — the most surprising longevity biomarker; Leong 2015 (PROSPECTIVE URBAN RURAL EPIDEMIOLOGY, N=142,861, 17 countries, 4-year follow-up): grip strength was a stronger predictor of cardiovascular mortality than systolic blood pressure; every 5kg reduction in grip strength → +17% higher risk of cardiovascular death, +7% higher risk of non-CV death; grip strength is a proxy for total skeletal muscle quality and neurological integrity; men target: ≥44kg dominant hand; women target: ≥27kg dominant hand; grip strength is modifiable with resistance training — decline is not inevitable with age; a $25 hand dynamometer provides one of the most data-backed longevity measurements available
Ready to build the full protocol?
The Longevity Stack ranks 20+ compounds by evidence tier — the full biomarker panel, VO2 max protocol, sleep science, hormone chapter, and three budget-level stacks, built from the same research on this page.
Get the Longevity Stack → $19

The 6 Longevity Biomarkers Worth Tracking

BiomarkerOptimal RangeHow to TestKey ResearchPrimary Modifier
VO2maxMen: >50 mL/kg/min; Women: >43 mL/kg/min (elite fitness, top quintile per age)Lab: metabolic cart (gold standard); Garmin/Apple Watch estimate (±10–15%); Rockport walk test; Cooper 12-min runMandsager 2018: strongest all-cause mortality predictor (N=122,007); every 3.5 mL/kg/min increase = -15% mortality riskZone 2 aerobic training (raises VO2max most durably); HIIT (raises faster, less durable); combination most effective
DunedinPACE≤0.95 (aging slower than chronological); >1.05 = accelerated agingTruAge COMPLETE test (methylation array from blood spot); Elysium Index; Morgan Levine's lab tests; bespoke labsBelsky 2020 (eLife): DunedinPACE validates against 18 organ-system health measures; strongly correlated with cognitive decline rate and grip strength decline rateCaloric restriction (most evidence); time-restricted eating; rapamycin (rodent data); exercise; sleep; smoking cessation (strong accelerant)
ApoB<60 mg/dL (longevity goal); <80 mg/dL (guideline); >120 mg/dL = high riskStandard blood draw (lab order); included in Function Health, InsideTracker panels; Quest/LabCorp with doctor's order or direct-to-consumerAMORIS study (N=175,553): ApoB stronger MI predictor than LDL-C; Ference 2019: lifetime ApoB exposure drives atherosclerosis progression linearly from birthStatins (lower ApoB ~40–50%); PCSK9 inhibitors (lower ApoB up to 60%); dietary: low saturated fat, high fiber; ezetimibe; bempedoic acid
Grip StrengthMen ≥44kg; Women ≥27kg (dominant hand); track trajectory, not just absolute levelHand dynamometer; measure 3× each hand, best of 6; available on Amazon (~$25–40)Leong 2015 (N=142,861): stronger CV predictor than blood pressure; Rantanen 1999: men in lowest grip strength quartile at 45 → 3× frailty risk at 65Resistance training (compound lifts, deadlifts, rows); farmer's carries; specific grip training; protein adequacy (1.5–2g/kg/day)
Fasting Insulin / HOMA-IRFasting insulin: <5 μIU/mL (optimal); HOMA-IR: <1.0 (optimal); most labs flag <25 as normal (missing pre-insulin resistance)Blood draw (must specify fasting insulin — NOT just fasting glucose); HOMA-IR = (fasting insulin × fasting glucose) ÷ 405Crofts 2015: subclinical hyperinsulinemia (fasting insulin 8–12) causes atherosclerosis years before glucose elevates; insulin resistance precedes T2DM by 10–15 yearsTime-restricted eating; low glycemic diet; resistance training (most evidence for insulin sensitization); Zone 2; metformin (if prescribed); berberine; weight loss
hsCRP<0.5 mg/L (longevity target); <1 mg/L (good); >3 mg/L = high cardiovascular riskStandard blood draw (hsCRP, not just CRP — high-sensitivity version); included in most comprehensive panelsRidker 2002 (NEJM): hsCRP adds predictive power for CV risk above and beyond LDL-C; JUPITER trial (N=17,802): statin therapy in low LDL but high hsCRP → -44% MACE; chronic low-grade inflammation drives all major age-related diseasesOmega-3 (1g EPA+DHA/day = -15–20% CRP); exercise (acute increase, chronic reduction); sleep (sleep deprivation raises CRP); weight loss; dental hygiene; smoking cessation
Practical Longevity Testing Protocol

Annual blood panel (order directly or through InsideTracker/Function Health): Comprehensive metabolic panel, CBC, lipid panel + ApoB, hsCRP, fasting insulin (must specify), HbA1c, homocysteine, 25(OH)D vitamin D, TSH/free T4, ferritin, Lp(a) (once in a lifetime — genetically fixed, no need to repeat unless on PCSK9 inhibitor). Cost via direct-to-consumer (LabCorp/Quest without insurance): ~$200–400 for full longevity panel. InsideTracker Ultimate (~$600) or Function Health ($499/year) include interpretation, trend tracking, and intervention suggestions.

Epigenetic clock testing (every 6–12 months if actively intervening): TruAge COMPLETE ($299 from TruDiagnostic) provides DunedinPACE + Horvath clock + 7 organ-system clocks; blood spot collected at home; 2–3 week turnaround; most useful as a response marker for interventions (track every 6 months when changing diet, exercise, or supplementation protocols); not useful as a one-time snapshot without longitudinal context.

VO2max testing: For accuracy: cardiac stress test with metabolic cart at a sports medicine clinic (~$250–400); for tracking: wearable estimate (Garmin or Apple Watch) systematically tested against the field Cooper 12-minute run (distance in meters − 504.9) ÷ 44.73 = VO2max; Garmin estimates typically within ±10% of lab values for consistent runners; more reliable for trained individuals than sedentary ones.

The one test most people are missing: Fasting insulin. Standard metabolic panels include fasting glucose and HbA1c — but these only elevate after years of insulin resistance. Fasting insulin elevates 10–15 years earlier. A fasting insulin above 8 μIU/mL (with normal glucose) indicates insulin resistance already present. Most people who discover this have no idea their metabolism was already dysregulated. This single lab value, costing ~$30–50 to add to any blood draw, is arguably the highest-value early-warning signal available for metabolic aging.

Hand Dynamometer → High-EPA Omega-3 →
Related longevity guides
Zone 2 Training → Cold Plunge → Sleep Science → Intermittent Fasting →

As an Amazon Associate, LongevityLab earns from qualifying purchases made through links on this page. This does not affect the price you pay.